Avista Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Avista Capital Partners has acquired 6 companies. It has also invested in 2 others.

Avista Capital Partners’ most common sectors for investment arelife science (27%) and medical products (16%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (35%) and secondary buyout (27%). In total, Avista Capital Partners has invested in 15 US states and 7 different countries. Its largest (disclosed) acquisition occurred in 2008 when it acquired ConvaTec for $4.1B.

In the last 3 years, Avista Capital Partners has exited 7 companies. The Firm’s most common exit type is trade sale (49%). Avista Capital Partners’ largest (disclosed) exit occurred in 2011 when it sold Nycomed Pharma AG for $10.8B.

Join Mergr to view Avista Capital Partners’ full profile and discover more mega-sized private equity firms just like it.

M&A Summary

M&A Total Activity75
- M&A Buy Activity46
- M&A Sell Activity29
Total Sectors Invested 18
Total Countries Invested 7
M&A Buy/Sell Connections 30
M&A Advisors 12

Avista Capital Partners

Transaction Criteria	Min	Max
Target Revenue	25	-
Target EBITDA	-	-
Investment Size	50	300
Enterprise Value	-	-
values in millions of USD

Transaction Criteria

Min

Max

Target Revenue

Target EBITDA

Investment Size

300

Enterprise Value

values in millions of USD

Year	≤ '16	'17	'18	'19	'20	'21	T
Buy (2.2/yr)	#	35	3	4	1	2	1	46
vol	$6.9B				$344M		$7.3B
Sell (1.6/yr)	#	21	1	4	1	-	2	29
vol	$17.4B		$525M	$402M			$18.3B
	75

Year

≤ '16

'17

'18

'19

'20

'21

Buy (2.2/yr)

vol

$6.9B

$344M

$7.3B

Sell (1.6/yr)

vol

$17.4B

$525M

$402M

$18.3B

Company	Date	Value	Type
Acino International AG	2021-09-16	-	Add-on Acquisition
Zurich, Czech Republic · www.acino.swiss
Arcadia Consumer Healthcare, Inc.	2021-08-09	-	Secondary Buyout
Bridgewater, New Jersey · www.arcadiach.com
eMolecules, Inc.	2021-03-25	-	Growth Capital
San Diego, California · www.emolecules.com
Solmetex LLC	2020-12-17	-	Secondary Buyout
Marlborough, Massachusetts · www.solmetex.com
Vision Healthcare N.V.	2020-06-01	344M EUR	Divestiture
Kortrijk, Belgium · www.visionhealthcare.eu
GCM Holding Corp.	2019-09-03	-	Secondary Buyout
Union, California · www.gogcm.com
Trimb Healthcare AB	2019-06-24	402M SEK	Add-on Acquisition
Stockholm, Sweden · www.trimb.se
Organogenesis, Inc.	2018-12-10	-	Secondary Buyout
Canton, Massachusetts · www.organogenesis.com
G&W Dermatology	2018-11-06	-	Divestiture
, New Jersey
Telular Corp.	2018-11-01	525M USD	Add-on Acquisition
Chicago, Illinois · www.telular.com
View All >>

Company

Date

Value

Type

Acino International AG

2021-09-16

Add-on Acquisition

Zurich, Czech Republic · www.acino.swiss

Arcadia Consumer Healthcare, Inc.

2021-08-09

Secondary Buyout

Bridgewater, New Jersey · www.arcadiach.com

eMolecules, Inc.

2021-03-25

Growth Capital

San Diego, California · www.emolecules.com

Solmetex LLC

2020-12-17

Secondary Buyout

Marlborough, Massachusetts · www.solmetex.com

Vision Healthcare N.V.

2020-06-01

344M EUR

Divestiture

Kortrijk, Belgium · www.visionhealthcare.eu

GCM Holding Corp.

2019-09-03

Secondary Buyout

Union, California · www.gogcm.com

Trimb Healthcare AB

2019-06-24

402M SEK

Add-on Acquisition

Stockholm, Sweden · www.trimb.se

Organogenesis, Inc.

2018-12-10

Secondary Buyout

Canton, Massachusetts · www.organogenesis.com

G&W Dermatology

2018-11-06

Divestiture

, New Jersey

Telular Corp.

2018-11-01

525M USD

Add-on Acquisition

Chicago, Illinois · www.telular.com

View All >>

Company	Acquired	Add-On/Sale	Date	#
Vision Healthcare N.V.	2020-06-01	NaturaMed Pharma AS	2020-12-21	2
Kortrijk, Belgium · www.visionhealthcare.eu	Drammen, Netherlands · www.naturamed-pharma.no

Company

Acquired

Add-On/Sale

Date

Vision Healthcare N.V.

2020-06-01

NaturaMed Pharma AS

2020-12-21

Kortrijk, Belgium · www.visionhealthcare.eu

Drammen, Netherlands · www.naturamed-pharma.no

Sector	Current #	Value	All-time #	Value
Life Science	6 (46%)	344M (100%)	12 (26%)	1.4B (19%)
Medical Products	1 (8%)	-	7 (15%)	4.6B (64%)
Oil/Gas Exploration	2 (15%)	-	5 (11%)	405M (6%)
Healthcare Services	1 (8%)	-	4 (9%)	635M (9%)
Energy Services and Equipment	-	-	3 (7%)	-
Information Technology	-	-	2 (4%)	253M (3%)
Communications	-	-	2 (4%)	-
Apparel/Textiles	-	-	1 (2%)	-
Automotive	-	-	1 (2%)	-
Business Services	-	-	1 (2%)	-
Consumer Products	-	-	1 (2%)	-
Distribution	-	-	1 (2%)	-
Environmental	-	-	1 (2%)	-
Machinery	1 (8%)	-	1 (2%)	-
Manufacturing	-	-	1 (2%)	-
Marketing	1 (8%)	-	1 (2%)	-
Publishing	-	-	1 (2%)	-
Software	1 (8%)	-	1 (2%)	-
Total	13	$344M	46	$7.3B

Sector

Current #

Value

All-time #

Value

Life Science

6 (46%)

344M (100%)

12 (26%)

1.4B (19%)

Medical Products

1 (8%)

7 (15%)

4.6B (64%)

Oil/Gas Exploration

2 (15%)

5 (11%)

405M (6%)

Healthcare Services

1 (8%)

4 (9%)

635M (9%)

Energy Services and Equipment

3 (7%)

Information Technology

2 (4%)

253M (3%)

Communications

2 (4%)

Apparel/Textiles

1 (2%)

Automotive

1 (2%)

Business Services

1 (2%)

Consumer Products

1 (2%)

Distribution

1 (2%)

Environmental

1 (2%)

Machinery

1 (8%)

1 (2%)

Manufacturing

1 (2%)

Marketing

1 (8%)

1 (2%)

Publishing

1 (2%)

Software

1 (8%)

1 (2%)

Total

$344M

$7.3B

State/Country	Current #	Value	All-time #	Value
United States	11 (85%)	-	39 (85%)	6.5B (90%)
	Texas	1 (8%)	-	8 (17%)	405M (6%)
	New Jersey	2 (15%)	-	6 (13%)	4.1B (56%)
	California	2 (15%)	-	5 (11%)	-
	Maryland	2 (15%)	-	4 (9%)	210M (3%)
	Massachusetts	2 (15%)	-	3 (7%)	525M (7%)
	Minnesota	1 (8%)	-	2 (4%)	-
	Pennsylvania	-	-	2 (4%)	-
	New York	-	-	2 (4%)	-
	Ohio	1 (8%)	-	1 (2%)	-
	North Carolina	-	-	1 (2%)	600M (8%)
	Illinois	-	-	1 (2%)	253M (3%)
	District of Columbia	-	-	1 (2%)	-
	Connecticut	-	-	1 (2%)	-
	Colorado	-	-	1 (2%)	-
United Kingdom	1 (8%)	-	2 (4%)	-
Belgium	1 (8%)	344M (100%)	1 (2%)	344M (5%)
Czech Republic	-	-	1 (2%)	414M (6%)
Denmark	-	-	1 (2%)	-
Sweden	-	-	1 (2%)	-
Switzerland	-	-	1 (2%)	-
Domestic	11 (85%)	-	39 (85%)	6.5B (90%)
Cross-border	2 (15%)	344M (100%)	7 (15%)	757M (10%)
Total	13	$344M	46	$7.3B

State/Country

Current #

Value

All-time #

Value

United States

11 (85%)

39 (85%)

6.5B (90%)

Texas

1 (8%)

8 (17%)

405M (6%)

New Jersey

2 (15%)

6 (13%)

4.1B (56%)

California

2 (15%)

5 (11%)

Maryland

2 (15%)

4 (9%)

210M (3%)

Massachusetts

2 (15%)

3 (7%)

525M (7%)

Minnesota

1 (8%)

2 (4%)

Pennsylvania

2 (4%)

New York

2 (4%)

Ohio

1 (8%)

1 (2%)

North Carolina

1 (2%)

600M (8%)

Illinois

1 (2%)

253M (3%)

District of Columbia

1 (2%)

Connecticut

1 (2%)

Colorado

1 (2%)

United Kingdom

1 (8%)

2 (4%)

Belgium

1 (8%)

344M (100%)

1 (2%)

344M (5%)

Czech Republic

1 (2%)

414M (6%)

Denmark

1 (2%)

Sweden

1 (2%)

Switzerland

1 (2%)

Domestic

11 (85%)

39 (85%)

6.5B (90%)

Cross-border

2 (15%)

344M (100%)

7 (15%)

757M (10%)

Total

$344M

$7.3B

Type	Current #	Value	All-time #	Value
Buyout (LBO, MBO, MBI)	1 (8%)	-	16 (35%)	350M (5%)
Secondary Buyout	5 (38%)	-	12 (26%)	600M (8%)
Divestiture	4 (31%)	344M (100%)	8 (17%)	5.6B (77%)
Growth Capital	2 (15%)	-	5 (11%)	-
Going Private	-	-	2 (4%)	667M (9%)
PIPE	1 (8%)	-	2 (4%)	-
Stake Purchase	-	-	1 (2%)	55M (1%)
Total	13	$344M	46	$7.3B

Type

Current #

Value

All-time #

Value

Buyout (LBO, MBO, MBI)

1 (8%)

16 (35%)

350M (5%)

Secondary Buyout

5 (38%)

12 (26%)

600M (8%)

Divestiture

4 (31%)

344M (100%)

8 (17%)

5.6B (77%)

Growth Capital

2 (15%)

5 (11%)

Going Private

2 (4%)

667M (9%)

PIPE

1 (8%)

2 (4%)

Stake Purchase

1 (2%)

55M (1%)

Total

$344M

$7.3B

Type	Total #	Value
Trade Sale - Public Company	12 (41%)	18.3B (100%)
IPO	5 (17%)	-
Secondary Sale	5 (17%)	-
Trade Sale	3 (10%)	-
Bankruptcy	1 (3%)	-
Merger	1 (3%)	-
Sold to Management	1 (3%)	-
Unknown	1 (3%)	-
Total	29	$18.3B

Type

Total #

Value

Trade Sale - Public Company

12 (41%)

18.3B (100%)

IPO

5 (17%)

Secondary Sale

5 (17%)

Trade Sale

3 (10%)

Bankruptcy

1 (3%)

Merger

1 (3%)

Sold to Management

1 (3%)

Unknown

1 (3%)

Total

$18.3B

Financial	Deals
Credit Suisse Investment Banking	2
UBS Investment Bank	1
SunTrust Robinson Humphrey, Inc.	1

Financial

Deals

Credit Suisse Investment Banking

UBS Investment Bank

SunTrust Robinson Humphrey, Inc.

Legal	Deals
Ropes & Gray LLP	6
Kirkland & Ellis LLP	5
Weil Gotshal & Manges LLP	4

Legal

Deals

Ropes & Gray LLP

Kirkland & Ellis LLP

Weil Gotshal & Manges LLP

buy	#	Total
> $1B	1	$4.1B
$100M to $1B	8	$3.1B
< $100M	1	$55M
TOTAL	$7.3B
Largest	ConvaTec, Inc. $4.1B (2008-08-02)

buy

Total

> $1B

$4.1B

$100M to $1B

$3.1B

< $100M

$55M

TOTAL

$7.3B

Largest

ConvaTec, Inc.
$4.1B (2008-08-02)

sell	#	Total
> $1B	4	$15.9B
$100M to $1B	6	$2.4B
TOTAL	$18.3B
Largest	Nycomed Pharma AG $10.8B (2011-05-19)

sell

Total

> $1B

$15.9B

$100M to $1B

$2.4B

TOTAL

$18.3B

Largest

Nycomed Pharma AG
$10.8B (2011-05-19)

		Deals
Acquired from
Investor(s)	26%	12 (26%)
Strategic(s)	13%	6 (13%)
Exited to
Investor(s)	17%	5 (17%)
Strategic(s)	52%	15 (52%)

Deals

Acquired from

Investor(s)

12 (26%)

Strategic(s)

6 (13%)

Exited to

Investor(s)

5 (17%)

Strategic(s)

15 (52%)

Avista Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

M&A Summary